- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
BioRestorative Therapies, a Melvillve, NY-based company that develops stem cell therapies, has applied for listing on the Nasdaq under the ticker symbol "BRTX."
|Latest market close||$1.60|
|52-week range||$1.41 - $7.13|
|50-day moving average||$2.64|
|200-day moving average||$3.50|
|Wall St. target price||$12.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-5.06|
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2023-09-15)||-4.19%|
|1 month (2023-08-22)||-37.25%|
|3 months (2023-06-22)||-71.17%|
|6 months (2023-03-22)||-50.61%|
|1 year (2022-09-22)||-43.46%|
|2 years (2021-09-22)||-87.50%|
|3 years (2020-09-22)||63.6|
|5 years (2018-09-21)||8680|
|Gross profit TTM||$119,800|
|Return on assets TTM||-69.43%|
|Return on equity TTM||-114.03%|
|Market Capitalization||$7.8 million|
TTM: trailing 12 months
We're not expecting BioRestorative Therapies to pay a dividend over the next 12 months.
BioRestorative Therapies's shares were split on a 1:4000 basis on 27 October 2021. So if you had owned 4000 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BioRestorative Therapies shares – just the quantity. However, indirectly, the new 399900% higher share price could have impacted the market appetite for BioRestorative Therapies shares which in turn could have impacted BioRestorative Therapies's share price.
Over the last 12 months, BioRestorative Therapies's shares have ranged in value from as little as $1.41 up to $7.13. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioRestorative Therapies's is 60.8582. This would suggest that BioRestorative Therapies's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put BioRestorative Therapies's beta into context you can compare it against those of similar companies.
BioRestorative Therapies, Inc. , a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc.
Everything we know about the Discord IPO, plus information on how to buy in.
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.